Monica Luchi

1.2k total citations
16 papers, 878 citations indexed

About

Monica Luchi is a scholar working on Rheumatology, Oncology and Surgery. According to data from OpenAlex, Monica Luchi has authored 16 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 4 papers in Oncology and 3 papers in Surgery. Recurrent topics in Monica Luchi's work include Rheumatoid Arthritis Research and Therapies (7 papers), Systemic Lupus Erythematosus Research (3 papers) and Bone health and treatments (2 papers). Monica Luchi is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (7 papers), Systemic Lupus Erythematosus Research (3 papers) and Bone health and treatments (2 papers). Monica Luchi collaborates with scholars based in United States, United Kingdom and Canada. Monica Luchi's co-authors include Scott D. Beattie, Peter Richardson, Peter Mesenbrink, Paul D. Miller, K. Zelenakas, Jacques P. Brown, William D. Fraser, Y. Saïdi, Guoqin Su and Kenneth W. Lyles and has published in prestigious journals such as New England Journal of Medicine, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Monica Luchi

16 papers receiving 848 citations

Peers

Monica Luchi

RHEUM

ONCOL

OSM

SURGE

HEMAT

Marie-Joëlle Kaiser Belgium

Anna Enjuanes Spain

Herbert Kellner Germany

Yukiko Komano Japan

O. Kaye Belgium

Vincenzo Pitini Italy

David C. Calverley United States

Lise Larsen Denmark

G. Schett Germany

B. Spriewald Germany

Marie-Joëlle Kaiser Belgium

Monica Luchi

534 ×1.0

RHEUM

78 ×0.2

ONCOL

51 ×0.3

OSM

159 ×1.0

SURGE

112 ×1.0

HEMAT

Citations per year, relative to Monica Luchi Monica Luchi (= 1×) peers Marie-Joëlle Kaiser

Countries citing papers authored by Monica Luchi

Since Specialization

Citations

This map shows the geographic impact of Monica Luchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Luchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Luchi more than expected).

Fields of papers citing papers by Monica Luchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Luchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Luchi. The network helps show where Monica Luchi may publish in the future.

Co-authorship network of co-authors of Monica Luchi

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Luchi. A scholar is included among the top collaborators of Monica Luchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Luchi. Monica Luchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Peterfy, Charles, Julie C. DiCarlo, Paul Emery, et al.. (2019). MRI and Dose Selection in a Phase II Trial of Baricitinib with Conventional Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis. The Journal of Rheumatology. 46(8). 887–895. 7 indexed citations

Bissonnette, Robert, Monica Luchi, Haifeng Zhang, et al.. (2016). A randomized, double-blind, placebo-controlled, dose-escalation study of the safety and efficacy of INCB039110, an oral janus kinase 1 inhibitor, in patients with stable, chronic plaque psoriasis. Journal of Dermatological Treatment. 27(4). 332–338. 63 indexed citations

Keystone, Edward, Peter C. Taylor, Edit Drescher, et al.. (2014). Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate. Annals of the Rheumatic Diseases. 74(2). 333–340. 225 indexed citations

Taylor, Peter C., Mark C. Genovese, Edward Keystone, et al.. (2013). 24-WEEK RESULTS OF A BLINDED PHASE IIB DOSE-RANGING STUDY OF BARICITINIB, AN ORAL JAK1/JAK2 INHIBITOR, IN COMBINATION WITH TRADITIONAL DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS. Lara D. Veeken. 52. 44–45. 1 indexed citations

Genovese, M. C., Ed Keystone, P. W. J. Taylor, et al.. (2012). 24-Week Results of a Blinded Phase 2b Dose-Ranging Study of Baricitinib, an Oral Janus Kinase 1/Januse Kinase 2 Inhibitor, in Combination with Traditional Disease Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis.. Oxford University Research Archive (ORA) (University of Oxford). 64(10). 10 indexed citations

Peterfy, Charles, Paul Emery, M. C. Genovese, et al.. (2012). Magnetic Resonance Imaging Substudy in a Phase 2b Dose-Ranging Study of Baricitinib, an Oral Janus Kinase 1/Janus Kinase 2 Inhibitor, in Combination with Traditional Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis.. Oxford University Research Archive (ORA) (University of Oxford). 8 indexed citations

Vaddi, Kris & Monica Luchi. (2012). JAK inhibition for the treatment of rheumatoid arthritis: a new era in oral DMARD therapy. Expert Opinion on Investigational Drugs. 21(7). 961–973. 22 indexed citations

Keystone, Ed, Peter C. Taylor, Mark C. Genovese, et al.. (2012). LB0005 12-week results of a phase 2B dose-ranging study of LY3009104 (INCB028050), an oral JAK1/JAK2 inhibitor, in combination with traditional dmards in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 71. 152–153. 14 indexed citations

Duryea, J., Jingbo Niu, Saara Tötterman, et al.. (2010). Comparison of radiographic joint space width with magnetic resonance imaging cartilage morphometry: Analysis of longitudinal data from the osteoarthritis initiative. Arthritis Care & Research. 62(7). 932–937. 96 indexed citations

10.

Hunter, David J., Jingbo Niu, Yuqing Zhang, et al.. (2008). Change in cartilage morphometry: a sample of the progression cohort of the Osteoarthritis Initiative. Annals of the Rheumatic Diseases. 68(3). 349–356. 96 indexed citations

11.

Luchi, Monica. (2007). Pneumonia before Antibiotics: Therapeutic Evolution and Evaluation in Twentieth-Century America. Journal of the History of Medicine and Allied Sciences. 63(1). 130–132. 1 indexed citations

12.

Reid, Ian R., Paul D. Miller, Kenneth W. Lyles, et al.. (2005). Comparison of a Single Infusion of Zoledronic Acid with Risedronate for Paget's Disease. New England Journal of Medicine. 353(9). 898–908. 281 indexed citations

13.

Soloway, Scott M., et al.. (1996). Soluble urate in sera and synovial fluids from patients with different joint disorders.. PubMed. 14(3). 249–54. 8 indexed citations

14.

Luchi, Monica, Ralph Schumacher, Samuel H. Zwillich, et al.. (1995). Detection of T Cell Receptors in Early Rheumatoid Arthritis Synovial Tissue. Pathobiology. 63(2). 100–108. 6 indexed citations

15.

Williams, William V., et al.. (1994). Immunotherapeutic strategies targeting rheumatoid synovial T-cell receptors by DNA inoculation. Immunologic Research. 13(2-3). 145–153. 3 indexed citations

16.

Luchi, Monica, Ronald A. Asherson, & Robert G. Lahita. (1992). Primary idiopathic pulmonary hypertension complicated by pulmonary arterial thrombosis. Association with antiphospholipid antibodies. Arthritis & Rheumatism. 35(6). 700–705. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact